Adenomyosis and IVF: Diagnosis, Treatment Planning, and Pregnancy Chances

Adenomyosis is a common uterine condition that can affect fertility, embryo implantation, miscarriage risk, and pregnancy comfort. With careful diagnosis and individualized IVF planning, many people with adenomyosis can still pursue pregnancy safely and realistically.

Overview: What Adenomyosis Means for IVF

Adenomyosis is a benign condition in which tissue similar to the endometrium, the lining of the uterus, is found within the myometrium, the muscular wall of the uterus. This can make the uterus enlarged, tender, or less flexible. Some people have clear symptoms such as heavy periods and pelvic pain, while others only discover adenomyosis during fertility testing.

For people planning in vitro fertilization, adenomyosis is important because IVF depends not only on embryo quality but also on a receptive uterine environment. The condition may influence implantation, early pregnancy development, and miscarriage risk. However, it does not mean pregnancy is impossible, and its effect differs from person to person.

Adenomyosis can occur alone, but it is often seen together with endometriosis, fibroids, polyps, or other causes of female infertility. A careful evaluation helps doctors understand whether adenomyosis is the main fertility concern or one factor among several. This distinction is central to building a realistic and personalized IVF plan.

Symptoms and How Adenomyosis May Affect Fertility

The symptoms of adenomyosis can overlap with many other gynecologic conditions. Common symptoms include heavy or prolonged menstrual bleeding, painful periods, pelvic pressure, pain during intercourse, and cramping that worsens over time. Some people also report bloating, fatigue related to heavy bleeding, or chronic pelvic discomfort between periods.

From a fertility perspective, adenomyosis may affect the uterus in several ways. It can be associated with local inflammation, altered immune signaling, changes in uterine blood flow, and stronger or irregular uterine contractions. These changes may make it more difficult for an embryo to implant or continue developing in early pregnancy.

It is also important to consider the emotional impact. People with adenomyosis may have lived for years with pain, heavy bleeding, or repeated unsuccessful attempts to conceive. A clear explanation of the diagnosis and a step-by-step fertility plan can help reduce uncertainty and support shared decision-making.

• Possible fertility effects: lower implantation rates in some patients, increased chance of early pregnancy loss, and a need for more careful embryo transfer planning.
• Possible pregnancy effects: closer monitoring may be recommended because adenomyosis has been associated in some studies with obstetric complications, although individual risk varies.

Causes and Risk Factors

The exact cause of adenomyosis is not fully understood. Several theories have been proposed, including movement of endometrial tissue into the uterine muscle, changes after uterine surgery, stem cell activity within the uterine wall, and hormonal or inflammatory influences. Estrogen appears to play a role, which is why symptoms often improve after menopause.

Adenomyosis is more commonly diagnosed in people in their late reproductive years, but improved ultrasound and MRI techniques mean it is increasingly recognized in younger patients undergoing fertility evaluation. It can occur in people who have never been pregnant, and it should not be dismissed solely because of age or reproductive history.

Risk factors that may be associated with adenomyosis include previous childbirth, previous uterine procedures, endometriosis, and fibroids. Still, many patients have no clear risk factor. In fertility care, the key question is less about why adenomyosis developed and more about how active, extensive, or clinically significant it is for the planned pregnancy attempt.

Diagnosis Before IVF: Ultrasound, MRI, and Fertility Workup

Diagnosis usually begins with a detailed medical history and pelvic examination, followed by imaging. Transvaginal ultrasound is often the first-line test because it is accessible and can show features such as an enlarged uterus, asymmetry of the uterine wall, myometrial cysts, fan-shaped shadowing, and an indistinct junctional zone. The accuracy of ultrasound depends greatly on equipment and the experience of the clinician performing the scan.

Pelvic MRI may be recommended when ultrasound findings are unclear, when adenomyosis appears extensive, or when treatment planning requires more detail. MRI can help assess the junctional zone, the depth and pattern of disease, and whether adenomyosis is diffuse or focal. It can also help distinguish adenomyosis from fibroids, which may require different management.

A complete IVF workup also includes assessment of ovarian reserve, partner or donor sperm factors, fallopian tube history when relevant, thyroid and metabolic health, and evaluation for coexisting conditions such as endometriosis or uterine cavity abnormalities. Hysteroscopy may be considered if there is concern about polyps, adhesions, or submucosal fibroids inside the uterine cavity.

There is no single blood test that confirms adenomyosis. Diagnosis is based on the combination of symptoms, examination, and imaging. For people considering IVF treatment, confirming the uterine diagnosis before embryo transfer can help avoid preventable delays and guide decisions about suppression, timing, and monitoring.

Treatment Planning Before and During IVF

Treatment planning depends on symptoms, age, ovarian reserve, the severity of adenomyosis, previous IVF history, and whether embryos are already available. Some patients proceed directly to ovarian stimulation, especially if time is important and symptoms are mild. Others may benefit from medical treatment before embryo transfer to calm the uterus and improve the chance of implantation.

Hormonal suppression is commonly discussed in adenomyosis-related IVF planning. Doctors may use medications that temporarily reduce estrogen stimulation of the uterus, such as gonadotropin-releasing hormone agonists or other hormonal options, depending on the patient’s situation. The aim is not to cure adenomyosis permanently, but to reduce disease activity and create a more favorable uterine environment before transfer.

Many fertility teams prefer a freeze-all approach in selected patients. This means embryos are created during an IVF cycle, frozen, and transferred later after the uterus has been prepared. A frozen embryo transfer can allow time for adenomyosis treatment, recovery from ovarian stimulation, and more controlled endometrial preparation.

Surgery is not the standard treatment for all adenomyosis patients before IVF, but it may be considered in specific situations, such as focal adenomyosis, severe symptoms, or distortion of the uterine cavity. Surgery on the uterine muscle requires careful discussion because it may affect uterine strength in pregnancy and may influence the recommended mode and timing of delivery. When sperm factors are present in addition to adenomyosis, options such as intracytoplasmic sperm injection may be included as part of the wider IVF plan.

Pregnancy Chances with Adenomyosis and IVF

Pregnancy chances with adenomyosis and IVF vary widely. Age, egg quality, embryo quality, ovarian reserve, body health, sperm quality, and the extent of uterine disease all matter. In general, adenomyosis may be associated with lower implantation rates and higher miscarriage rates in some studies, but many patients still achieve ongoing pregnancies and live births.

The outlook is often more favorable when the diagnosis is made before embryo transfer rather than after repeated unsuccessful cycles. Early diagnosis gives the fertility team time to optimize the uterine environment, consider a frozen transfer strategy, manage pain or bleeding, and review whether coexisting endometriosis, fibroids, or polyps are also present.

Embryo quality is another major factor. Even with a well-prepared uterus, embryos with significant chromosomal abnormalities are less likely to implant or continue developing. In some cases, preimplantation genetic testing may be discussed, particularly for patients of advanced reproductive age or those with recurrent pregnancy loss, but it is not required for everyone.

Patients should be cautious about comparing their chances with online stories or general statistics. Adenomyosis is not a single uniform condition; mild focal disease and severe diffuse disease may behave differently. The most useful estimate comes from a fertility specialist who can review imaging, reproductive history, embryo information, and general health together.

Prevention, Self-Care, and Preparing the Body for IVF

There is no proven way to prevent adenomyosis, and having the condition is not the patient’s fault. Self-care cannot remove adenomyosis, but it can support comfort, overall health, and readiness for fertility treatment. Managing anemia from heavy bleeding, improving sleep, addressing chronic pain, and maintaining a balanced diet can make the IVF process easier to tolerate.

Patients should tell their doctor about severe menstrual pain, heavy bleeding, bleeding between periods, pain during intercourse, or past diagnoses of endometriosis or fibroids. Treating iron deficiency, optimizing thyroid function, reviewing medications, and managing chronic conditions such as diabetes or hypertension are important before pregnancy. Smoking cessation and limiting alcohol are also commonly recommended for fertility and pregnancy health.

Stress does not cause adenomyosis, and patients should not feel responsible for the condition. Still, IVF can be emotionally demanding, especially after previous losses or failed cycles. Counseling, support groups, and clear communication with the fertility team can help patients make decisions without feeling rushed.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals evaluate and treat adenomyosis, IVF-related concerns, and broader infertility needs for international patients. Care is individualized, with coordination between reproductive medicine, gynecology, imaging, and pregnancy care teams when needed.

When to See a Doctor

A medical evaluation is recommended if periods are very heavy, pain interferes with daily life, pelvic pain is worsening, or pregnancy has not occurred after a reasonable period of trying. People aged 35 or older, or those with known endometriosis, fibroids, irregular cycles, or previous pregnancy loss, may benefit from earlier fertility consultation.

Anyone planning IVF should ask whether the uterus has been carefully assessed before embryo transfer. If adenomyosis is suspected, a second opinion from a fertility specialist or gynecologist experienced in reproductive imaging may be helpful. This is especially important after repeated implantation failure, recurrent miscarriage, or unexplained poor IVF outcomes.

Urgent medical care is appropriate for very heavy bleeding with dizziness or fainting, severe sudden pelvic pain, fever, or symptoms of pregnancy complications. During pregnancy after adenomyosis and IVF, patients should attend all scheduled prenatal visits and report bleeding, persistent pain, fluid leakage, or reduced fetal movements later in pregnancy according to their obstetrician’s guidance.

Frequently asked questions

Can a person with adenomyosis get pregnant with IVF?

Yes, pregnancy is possible with adenomyosis and IVF. The chance depends on age, embryo quality, the severity of adenomyosis, and other fertility factors. A personalized plan may include medical suppression, frozen embryo transfer, or treatment of coexisting uterine conditions.

Does adenomyosis always reduce IVF success?

No, adenomyosis does not affect every patient in the same way. Some people have mild disease and good IVF outcomes, while others may have implantation failure or miscarriage risk related to more extensive disease. Imaging and previous fertility history help doctors estimate its likely impact.

Is MRI necessary before IVF if adenomyosis is suspected?

MRI is not necessary for every patient, but it can be very useful when ultrasound findings are uncertain or when adenomyosis appears severe. It provides more detail about the uterine muscle and junctional zone. The decision depends on symptoms, scan quality, and treatment planning needs.

Should adenomyosis be treated before embryo transfer?

Sometimes treatment before embryo transfer is recommended, especially if symptoms are significant, the uterus is enlarged, or there have been previous failed transfers or miscarriages. Treatment may involve hormonal suppression or a delayed frozen embryo transfer. The best approach should be individualized by a fertility specialist.

Can surgery improve IVF chances in adenomyosis?

Surgery may help selected patients with focal adenomyosis or severe symptoms, but it is not routinely advised for everyone. Because adenomyosis involves the uterine muscle, surgery can carry risks for future pregnancy and must be carefully planned. Medical treatment is often considered first.

Is fresh or frozen embryo transfer better for adenomyosis?

There is no single answer for all patients. In many adenomyosis cases, a frozen embryo transfer may be preferred because it allows time for uterine preparation and hormonal suppression if needed. The decision should consider embryo number, ovarian response, uterine findings, and previous IVF outcomes.

Does adenomyosis make pregnancy high risk?

Adenomyosis may be associated with certain pregnancy risks in some patients, but risk varies widely. Many pregnancies progress well with appropriate monitoring. Patients should have coordinated care between their fertility specialist and obstetrician, especially after IVF or previous pregnancy complications.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.